An ENaC inhibitor
Related Products
Analytical Standard(s)
22486Triamterene
Labeled Version(s)
33815Triamterene-d5
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Triamterene

Item No. 21242

Technical Information
Formal Name
6-phenyl-2,4,7-pteridinetriamine
CAS Number
396-01-0
Synonyms
  • NSC 77625
  • SKF 8542
  • 2,4,7-Triamino-6-phenylpteridine
Molecular Formula
C12H11N7
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMSO: 1 mg/mlDMSO:PBS(pH 7.2) (1:4): 0.2 mg/ml
λmax
232, 271, 367 nm
SMILES
NC1=NC(N)=NC(N=C2N)=C1N=C2C3=CC=CC=C3
InChi Code
InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19)
InChi Key
FNYLWPVRPXGIIP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Triamterene is an inhibitor of the epithelial sodium channel (ENaC; IC50 = 4.5 µM for the rat channel).1 In vivo, triamterene (0.5-32 mg/animal) enhances sodium secretion and decreases potassium secretion in adrenalectomized rats.2 Formulations containing triamterene have been used in the treatment of edema. This product is also available as an analytical reference standard (Item No. 22486).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kellenberger, S., Gautschi, I., and Schlid, L. Mutations in the epithelial Na+ channel ENaC outer pore disrupt amiloride block by increasing its dissociation rate. Mol. Pharmacol. 64(4), 848-856 (2003).

    2. Baba, W.I., Tudhope, G.R., and Wilson, G.M. Triamterene, a new diuretic drug. I. Studies in normal men and in adrenalectomized rats. Br. Med. J. 2(5307), 756-760 (1962).